Tirzepatide: Three new post hoc analyzes support efficacy in type 2 diabetes

Tirzepatide: Three new post hoc analyzes support efficacy in type 2 diabetes

0 Comments

Berlin – Tirzepatide reduces HbA1c and body weight compared to placebo or semaglutide, regardless of basal beta-cell function. This emerges from a post-hoc analysis of the SURPASS 1 and 2 studies by Thomas Forst, CRS Clinical Research Services Mannheim… [weiter lesen]

#Tirzepatide #post #hoc #analyzes #support #efficacy #type #diabetes

Leave a Reply

Related Posts